Identification of human brain tumour initiating cells
- PMID: 15549107
- DOI: 10.1038/nature03128
Identification of human brain tumour initiating cells
Abstract
The cancer stem cell (CSC) hypothesis suggests that neoplastic clones are maintained exclusively by a rare fraction of cells with stem cell properties. Although the existence of CSCs in human leukaemia is established, little evidence exists for CSCs in solid tumours, except for breast cancer. Recently, we prospectively isolated a CD133+ cell subpopulation from human brain tumours that exhibited stem cell properties in vitro. However, the true measures of CSCs are their capacity for self renewal and exact recapitulation of the original tumour. Here we report the development of a xenograft assay that identified human brain tumour initiating cells that initiate tumours in vivo. Only the CD133+ brain tumour fraction contains cells that are capable of tumour initiation in NOD-SCID (non-obese diabetic, severe combined immunodeficient) mouse brains. Injection of as few as 100 CD133+ cells produced a tumour that could be serially transplanted and was a phenocopy of the patient's original tumour, whereas injection of 10(5) CD133- cells engrafted but did not cause a tumour. Thus, the identification of brain tumour initiating cells provides insights into human brain tumour pathogenesis, giving strong support for the CSC hypothesis as the basis for many solid tumours, and establishes a previously unidentified cellular target for more effective cancer therapies.
Comment in
-
Neurobiology: at the root of brain cancer.Nature. 2004 Nov 18;432(7015):281-2. doi: 10.1038/432281a. Nature. 2004. PMID: 15549078 No abstract available.
Similar articles
-
The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.Eur J Cardiothorac Surg. 2009 Sep;36(3):446-53. doi: 10.1016/j.ejcts.2009.03.063. Epub 2009 May 22. Eur J Cardiothorac Surg. 2009. PMID: 19464919
-
Culture and isolation of brain tumor initiating cells.Curr Protoc Stem Cell Biol. 2009 Oct;Chapter 3:Unit3.3. doi: 10.1002/9780470151808.sc0303s11. Curr Protoc Stem Cell Biol. 2009. PMID: 19816962
-
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.Nature. 2007 Jan 4;445(7123):106-10. doi: 10.1038/nature05372. Epub 2006 Nov 19. Nature. 2007. PMID: 17122772
-
How powerful is CD133 as a cancer stem cell marker in brain tumors?Cancer Treat Rev. 2009 Aug;35(5):403-8. doi: 10.1016/j.ctrv.2009.03.002. Epub 2009 Apr 14. Cancer Treat Rev. 2009. PMID: 19369008 Review.
-
Insight into the complex regulation of CD133 in glioma.Int J Cancer. 2011 Feb 1;128(3):501-10. doi: 10.1002/ijc.25687. Int J Cancer. 2011. PMID: 20853315 Review.
Cited by
-
Synergistic Dual Targeting of Thioredoxin and Glutathione Systems Irrespective of p53 in Glioblastoma Stem Cells.Antioxidants (Basel). 2024 Oct 3;13(10):1201. doi: 10.3390/antiox13101201. Antioxidants (Basel). 2024. PMID: 39456455 Free PMC article.
-
Anti-Cancer Effect of Ginsenoside F2 against Glioblastoma Multiforme in Xenograft Model in SD Rats.J Ginseng Res. 2012 Jan;36(1):86-92. doi: 10.5142/jgr.2012.36.1.86. J Ginseng Res. 2012. PMID: 23717108 Free PMC article.
-
A novel zebrafish xenotransplantation model for study of glioma stem cell invasion.PLoS One. 2013 Apr 16;8(4):e61801. doi: 10.1371/journal.pone.0061801. Print 2013. PLoS One. 2013. PMID: 23613942 Free PMC article.
-
Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells.PLoS One. 2015 Feb 27;10(2):e0118933. doi: 10.1371/journal.pone.0118933. eCollection 2015. PLoS One. 2015. PMID: 25723399 Free PMC article.
-
Identification of inhibitors of ovarian cancer stem-like cells by high-throughput screening.J Ovarian Res. 2012 Oct 18;5(1):30. doi: 10.1186/1757-2215-5-30. J Ovarian Res. 2012. PMID: 23078816 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous